Opioids Preserve the Adrenal Medullary Response Evoked by Severe Hemorrhage
Open Access
- 1 May 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 68 (5) , 743-753
- https://doi.org/10.1097/00000542-198805000-00012
Abstract
Possible modulatory effects of .mu.-, .delta.-, and .kappa.-receptor agonists on the concurrent adrenal secretion of catecholamines and met-enkephalin evoked by staged hemorrhage were examined in four groups of cats (n = 5 in each grup) anesthetized with halothane (1 MAC). Group I received saline, group II received the .mu.-agonist sufentanil (25 .mu.g/kg i.v., followed by a maintenance infusion), group III received the .delta./.mu. agonist metkephamid (3 mg/kg i.v.), and group IV the .kappa. agonist U50488H (3.5 mg/kg i.v.). Samples for norepinephrine, epinephrine, dopamine, and met-enkephalin were taken simultaneously from the adrenal vein, femoral vein, and femoral artery at baseline, after drug administration, and after induction of 25% and 50% hemorrhage. In cats receiving saline, 25% hemorrhage resulted in a significant decline in mean arterial blood pressure (MABP) and no change in adrenal secretion. Fifty percent hemorrhage evoked no significant further fall in MABP, but led to prominent increases in adrenal vein hormone levels (norepinephrine, 30-fold; dopamine, 14-fold; and epinephrine, ten-fold) as compared to post-saline values. During the pre-hemorrhage baseline state, administration of sufentanil evoked a significant six- to 20-fold rise in adrenal vein catecholamine and met-enkephalin levels, whereas the administration of metkephamid and U50488H produced no change in adrenal secretion and a decrease in MABP. After 25% and 50% hemorrhage, there was no difference in adrenal vein hormone levels in cats receiving the .mu.-, .delta.-, or .kappa.-agonists compared to those receiving saline. No differences were observed in the different treatment groups with regard to the proportional levels of catecholamines and met-enkephalin in the adrenal vein during the course of the experiment. The authors conclude that opioids are not involved in the regulation of the secretory adrenal medullary response evoked by hemorrhage, and that the systems involved in mediating these cardiovascular reflexes differ pharmacologically from those systems mediating the autonomic response evoked by pain.This publication has 20 references indexed in Scilit:
- α-Receptors Mediate Opioid Cardiovascular Effects at Anterior Hypothalamic Sites through Sympatho- Adrenomedullary and Parasympathetic Pathways*Endocrinology, 1983
- U-50,488 - A SELECTIVE AND STRUCTURALLY NOVEL NON-MU-(KAPPA)-OPIOID AGONIST1983
- Pulmonary vagal afferent stimulants in the conscious rat: Opioids and phenyldiguanidePharmacology Biochemistry and Behavior, 1982
- Anesthetic Doses Blocking Adrenergic (Stress) and Cardiovascular Responses to Incision—MAC BARAnesthesiology, 1981
- Metkephamid, a Systemically Active Analog of Methionine Enkephalin with Potent Opioid δ-Receptor ActivityScience, 1981
- Enkephalin‐like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary gland cellsActa Physiologica Scandinavica, 1978
- Inhibition by etorphine of the discharge of dorsal horn neurons: Effects on the neuronal response to both high- and low-threshold sensory input in the decerebrate spinal catExperimental Neurology, 1978
- The mechanism of inhibition of neuronal activity by opiates in the spinal cord of catBrain Research, 1976
- Role of the sympathetic nervous system in hemorrhage.Physiological Reviews, 1967
- A COMPARATIVE STUDY OF THE EFFECTS OF MORPHINE IN UNANAESTHETIZED AND ANAESTHETIZED CATSBritish Journal of Pharmacology and Chemotherapy, 1966